• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用含碳纳米管的纳米流体评价针对分枝杆菌属的抗生素传递。

Antibiotic delivery evaluation against Mycobacterium fortuitum using nanofluids containing carbon nanotubes.

机构信息

Department of Biology, Faculty of Life Sciences, Danesh Alborz University, Abyek, Iran.

Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.

出版信息

BMC Microbiol. 2022 Apr 11;22(1):96. doi: 10.1186/s12866-022-02523-z.

DOI:10.1186/s12866-022-02523-z
PMID:35410123
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8996581/
Abstract

BACKGROUND

Mycobacterium fortuitum (M. fortuitum) is a bacterium, which can cause infections in many anatomical regions of the body, including the skin, lymph nodes, and joints. This bacterium, which belongs to a group of bacteria known as nontuberculous mycobacteria, is regarded as an important nosocomial pathogen worldwide owing to its increasing antibiotic resistance. Recently, the antimicrobial effects of carbon nanotubes have been reported in numerous studies. These nanotubes can be very useful in drug delivery; besides, they exhibit unique properties against multidrug-resistant bacterial infections. This study aimed to investigate the antimicrobial effects of carboxyl-functionalized multi-walled carbon nanotubes (MWCNT-COOH) to reduce antibiotic resistance.

METHODS

In this study, antibacterial effects of nanofluids containing functionalized MWCNTs at initial concentration of 2 mg/mL and serial dilutions of 54, 28.5, 14.25, 7.12, 3.5 µg/mL, antibiotics alone and combination of nanofluids with antibiotics were investigated. Standard and resistant strains of M. fortuitum were obtained from the microbial bank of the Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran.

RESULTS

It was observed that nanofluid containing MWCNT-COOH can exert antimicrobial effects on M. fortuitum and significantly reduce bacterial resistance to antibiotics including kanamycin and streptomycin. In the presence of antibiotics and nanofluids containing MWCNT-COOH at a dose of 28.5 µg/mL, no growth was observed.

CONCLUSION

One of the main antimicrobial mechanisms of MWCNT-COOH is penetration into the bacterial cell wall. In this study, by using the nanofluid containing MWCNT-COOH with increased stability, the antibiotic resistance of M. fortuitum was significantly reduced at lower dilutions compared to the antibiotic alone.

摘要

背景

偶然分枝杆菌(M. fortuitum)是一种细菌,可引起身体许多解剖部位的感染,包括皮肤、淋巴结和关节。这种细菌属于非结核分枝杆菌群,由于其抗生素耐药性不断增加,已被认为是全球重要的医院病原体。最近,许多研究报道了碳纳米管的抗菌作用。这些纳米管在药物输送方面非常有用;此外,它们对多药耐药细菌感染具有独特的特性。本研究旨在研究羧基功能化多壁碳纳米管(MWCNT-COOH)的抗菌作用,以降低抗生素耐药性。

方法

在这项研究中,研究了初始浓度为 2 mg/mL 及 54、28.5、14.25、7.12、3.5μg/mL 等系列稀释浓度的含功能化 MWCNT 的纳米流体对标准和耐药分枝杆菌的抗菌作用。偶然分枝杆菌标准和耐药株均来自伊朗巴斯德研究所分枝杆菌和肺部研究微生物库。

结果

结果表明,含 MWCNT-COOH 的纳米流体对偶然分枝杆菌具有抗菌作用,并能显著降低分枝杆菌对包括卡那霉素和链霉素在内的抗生素的耐药性。在含抗生素和 MWCNT-COOH 的纳米流体剂量为 28.5μg/mL 的情况下,没有观察到细菌生长。

结论

MWCNT-COOH 的主要抗菌机制之一是穿透细菌细胞壁。在本研究中,通过使用稳定性更高的含 MWCNT-COOH 的纳米流体,与单独使用抗生素相比,在较低稀释度下,偶然分枝杆菌的抗生素耐药性显著降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/399a/8996581/aeaab1404716/12866_2022_2523_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/399a/8996581/649af3140922/12866_2022_2523_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/399a/8996581/7102c2e9911f/12866_2022_2523_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/399a/8996581/aeaab1404716/12866_2022_2523_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/399a/8996581/649af3140922/12866_2022_2523_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/399a/8996581/7102c2e9911f/12866_2022_2523_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/399a/8996581/aeaab1404716/12866_2022_2523_Fig3_HTML.jpg

相似文献

1
Antibiotic delivery evaluation against Mycobacterium fortuitum using nanofluids containing carbon nanotubes.利用含碳纳米管的纳米流体评价针对分枝杆菌属的抗生素传递。
BMC Microbiol. 2022 Apr 11;22(1):96. doi: 10.1186/s12866-022-02523-z.
2
The Effects Study of Isoniazid Conjugated Multi-Wall Carbon Nanotubes Nanofluid on .异烟肼偶联多壁碳纳米管纳米流体的作用研究。
Int J Nanomedicine. 2020 Aug 13;15:5901-5909. doi: 10.2147/IJN.S251524. eCollection 2020.
3
Is the Antibacterial Activity of Multi-Walled Carbon Nanotubes (MWCNTs) Related to Antibiotic Resistance? An Assessment in Clinical Isolates.多壁碳纳米管(MWCNTs)的抗菌活性与抗生素耐药性有关吗?临床分离株的评估。
Int J Environ Res Public Health. 2021 Sep 3;18(17):9310. doi: 10.3390/ijerph18179310.
4
Susceptibility of and Isolates to 30 Antibiotics.30 种抗生素对 及 分离株的敏感性。
Biomed Res Int. 2018 Dec 30;2018:4902941. doi: 10.1155/2018/4902941. eCollection 2018.
5
Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis and treatment.分枝杆菌性角膜炎的局部抗菌治疗:手术预防和治疗的潜力
Clin Ther. 2004 Feb;26(2):191-6. doi: 10.1016/s0149-2918(04)90018-5.
6
Characterisation of porin genes from Mycobacterium fortuitum and their impact on growth.偶然分枝杆菌孔蛋白基因的表征及其对生长的影响。
BMC Microbiol. 2009 Feb 9;9:31. doi: 10.1186/1471-2180-9-31.
7
An efficient growth of silver and copper nanoparticles on multiwalled carbon nanotube with enhanced antimicrobial activity.多壁碳纳米管上高效生长的银和铜纳米颗粒,具有增强的抗菌活性。
J Biomed Mater Res B Appl Biomater. 2011 Jan;96(1):119-26. doi: 10.1002/jbm.b.31747.
8
General characteristics, features of cultivation and antibiotic resistance representatives of mycobacterium fortuitum group representatives (review of literature).分枝杆菌偶发菌属代表种的一般特征、培养特性和抗生素耐药性(文献综述)。
Klin Lab Diagn. 2021 Apr 17;66(4):223-228. doi: 10.51620/0869-2084-2021-66-4-223-228.
9
Successful bedaquiline-containing antimycobacterial treatment in post-traumatic skin and soft-tissue infection by Mycobacterium fortuitum complex: a case report.成功治疗外伤后由偶发分枝杆菌复合群引起的皮肤和软组织感染:病例报告。
BMC Infect Dis. 2020 May 24;20(1):365. doi: 10.1186/s12879-020-05075-7.
10
Microbial toxicity of ethanolamines--multiwalled carbon nanotubes.乙醇胺的微生物毒性——多壁碳纳米管
J Biomed Mater Res A. 2014 Jun;102(6):1774-81. doi: 10.1002/jbm.a.34846. Epub 2013 Jun 28.

引用本文的文献

1
Carbon Nanomaterial Fluorescent Probes and Their Biological Applications.碳纳米材料荧光探针及其生物应用。
Chem Rev. 2024 Mar 27;124(6):3085-3185. doi: 10.1021/acs.chemrev.3c00581. Epub 2024 Mar 13.
2
Anti-Infective and Toxicity Properties of Carbon Based Materials: Graphene and Functionalized Carbon Nanotubes.碳基材料的抗感染和毒性特性:石墨烯及功能化碳纳米管
Microorganisms. 2022 Dec 9;10(12):2439. doi: 10.3390/microorganisms10122439.

本文引用的文献

1
An in Vitro Study of Molecular Effects of a Combination Treatment with Antibiotics and Nanofluid Containing Carbon Nano-tubes on .抗生素与含碳纳米管的纳米流体联合治疗的分子效应的体外研究 。 需注意,原文结尾“on.”后面内容缺失,翻译可能不太完整准确。
Iran J Public Health. 2021 Nov;50(11):2292-2301. doi: 10.18502/ijph.v50i11.7585.
2
Phenotypic and genomic hallmarks of a novel, potentially pathogenic rapidly growing Mycobacterium species related to the Mycobacterium fortuitum complex.新型潜在致病性快速生长分枝杆菌种的表型和基因组特征,该种与偶然分枝杆菌复合体相关。
Sci Rep. 2021 Jun 21;11(1):13011. doi: 10.1038/s41598-021-91737-8.
3
Gene Sequencing and Phylogenetic Analysis: Powerful Tools for an Improved Diagnosis of Fish Mycobacteriosis Caused by Group Members.
基因测序与系统发育分析:用于改进由分枝杆菌属成员引起的鱼类分枝杆菌病诊断的强大工具。
Microorganisms. 2021 Apr 10;9(4):797. doi: 10.3390/microorganisms9040797.
4
Drug Resistance in Nontuberculous Mycobacteria: Mechanisms and Models.非结核分枝杆菌中的耐药性:机制与模型
Biology (Basel). 2021 Jan 29;10(2):96. doi: 10.3390/biology10020096.
5
The Effects Study of Isoniazid Conjugated Multi-Wall Carbon Nanotubes Nanofluid on .异烟肼偶联多壁碳纳米管纳米流体的作用研究。
Int J Nanomedicine. 2020 Aug 13;15:5901-5909. doi: 10.2147/IJN.S251524. eCollection 2020.
6
Synthesis of Dihydromyricetin Coated Multi-Walled Carbon Nanotubes (MWCNTs) and Antibacterial Activities.二氢杨梅素包覆多壁碳纳米管(MWCNTs)的合成及其抗菌活性。
J Nanosci Nanotechnol. 2020 Oct 1;20(10):6148-6154. doi: 10.1166/jnn.2020.18002.
7
Nanomedicine Fight against Antibacterial Resistance: An Overview of the Recent Pharmaceutical Innovations.纳米医学对抗抗菌药物耐药性:近期药物创新概述
Pharmaceutics. 2020 Feb 8;12(2):142. doi: 10.3390/pharmaceutics12020142.
8
Non-tuberculous mycobacterial pulmonary disease.非结核分枝杆菌肺病。
Eur Respir J. 2019 Jul 11;54(1). doi: 10.1183/13993003.00250-2019. Print 2019 Jul.
9
Two Component Regulatory Systems and Antibiotic Resistance in Gram-Negative Pathogens.革兰氏阴性病原体中的两成分调控系统与抗生素耐药性。
Int J Mol Sci. 2019 Apr 10;20(7):1781. doi: 10.3390/ijms20071781.
10
Susceptibility of and Isolates to 30 Antibiotics.30 种抗生素对 及 分离株的敏感性。
Biomed Res Int. 2018 Dec 30;2018:4902941. doi: 10.1155/2018/4902941. eCollection 2018.